129 related articles for article (PubMed ID: 20587341)
1. Liver-directed gene expression using recombinant AAV 2/8 vectors--a tolerogenic strategy for gene delivery?
Sharland A; Logan GJ; Bishop A; Alexander IE
Discov Med; 2010 Jun; 9(49):519-27. PubMed ID: 20587341
[TBL] [Abstract][Full Text] [Related]
2. Recombinant adeno-associated virus vector: Is it ideal for gene delivery in liver transplantation?
Yang ZF; Wu XB; Tsui TY; Hou YD; Luk JM; Fan ST
Liver Transpl; 2003 Apr; 9(4):411-20. PubMed ID: 12682895
[TBL] [Abstract][Full Text] [Related]
3. Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors.
Raake PW; Hinkel R; Müller S; Delker S; Kreuzpointner R; Kupatt C; Katus HA; Kleinschmidt JA; Boekstegers P; Müller OJ
Gene Ther; 2008 Jan; 15(1):12-7. PubMed ID: 17943147
[TBL] [Abstract][Full Text] [Related]
4. Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors.
Sarukhan A; Camugli S; Gjata B; von Boehmer H; Danos O; Jooss K
J Virol; 2001 Jan; 75(1):269-77. PubMed ID: 11119597
[TBL] [Abstract][Full Text] [Related]
5. Biology of AAV serotype vectors in liver-directed gene transfer to nonhuman primates.
Gao G; Lu Y; Calcedo R; Grant RL; Bell P; Wang L; Figueredo J; Lock M; Wilson JM
Mol Ther; 2006 Jan; 13(1):77-87. PubMed ID: 16219492
[TBL] [Abstract][Full Text] [Related]
6. Strategies for improving the transduction efficiency of single-stranded adeno-associated virus vectors in vitro and in vivo.
Jayandharan GR; Zhong L; Li B; Kachniarz B; Srivastava A
Gene Ther; 2008 Sep; 15(18):1287-93. PubMed ID: 18496572
[TBL] [Abstract][Full Text] [Related]
7. Improved neuronal transgene expression from an AAV-2 vector with a hybrid CMV enhancer/PDGF-beta promoter.
Wang CY; Guo HY; Lim TM; Ng YK; Neo HP; Hwang PY; Yee WC; Wang S
J Gene Med; 2005 Jul; 7(7):945-55. PubMed ID: 15756650
[TBL] [Abstract][Full Text] [Related]
8. Myocardial gene transfer and long-term expression following intracoronary delivery of adeno-associated virus.
Kaspar BK; Roth DM; Lai NC; Drumm JD; Erickson DA; McKirnan MD; Hammond HK
J Gene Med; 2005 Mar; 7(3):316-24. PubMed ID: 15515115
[TBL] [Abstract][Full Text] [Related]
9. Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.
High KA
Trans Am Clin Climatol Assoc; 2003; 114():337-51; discussion 351-2. PubMed ID: 12813929
[TBL] [Abstract][Full Text] [Related]
10. High-level transgene expression in nonhuman primate liver with novel adeno-associated virus serotypes containing self-complementary genomes.
Gao GP; Lu Y; Sun X; Johnston J; Calcedo R; Grant R; Wilson JM
J Virol; 2006 Jun; 80(12):6192-4. PubMed ID: 16731960
[TBL] [Abstract][Full Text] [Related]
11. Improved transduction of primary murine hepatocytes by recombinant adeno-associated virus 2 vectors in vivo.
Zhong L; Li W; Yang Z; Chen L; Li Y; Qing K; Weigel-Kelley KA; Yoder MC; Shou W; Srivastava A
Gene Ther; 2004 Jul; 11(14):1165-9. PubMed ID: 15164097
[TBL] [Abstract][Full Text] [Related]
12. Adeno-associated viral vectors for gene transfer and gene therapy.
Büeler H
Biol Chem; 1999 Jun; 380(6):613-22. PubMed ID: 10430026
[TBL] [Abstract][Full Text] [Related]
13. Stable transduction of large DNA by high-capacity adeno-associated virus/adenovirus hybrid vectors.
Gonçalves MA; van der Velde I; Knaän-Shanzer S; Valerio D; de Vries AA
Virology; 2004 Apr; 321(2):287-96. PubMed ID: 15051388
[TBL] [Abstract][Full Text] [Related]
14. Immunity to adeno-associated virus serotype 2 delivered transgenes imparted by genetic predisposition to autoimmunity.
Zhang YC; Powers M; Wasserfall C; Brusko T; Song S; Flotte T; Snyder RO; Potter M; Scott-Jorgensen M; Campbell-Thompson M; Crawford JM; Nick HS; Agarwal A; Ellis TM; Atkinson MA
Gene Ther; 2004 Feb; 11(3):233-40. PubMed ID: 14737082
[TBL] [Abstract][Full Text] [Related]
15. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors.
Snyder RO; Miao CH; Patijn GA; Spratt SK; Danos O; Nagy D; Gown AM; Winther B; Meuse L; Cohen LK; Thompson AR; Kay MA
Nat Genet; 1997 Jul; 16(3):270-6. PubMed ID: 9207793
[TBL] [Abstract][Full Text] [Related]
16. Self-complementary adeno-associated virus 2 (AAV)-T cell protein tyrosine phosphatase vectors as helper viruses to improve transduction efficiency of conventional single-stranded AAV vectors in vitro and in vivo.
Zhong L; Chen L; Li Y; Qing K; Weigel-Kelley KA; Chan RJ; Yoder MC; Srivastava A
Mol Ther; 2004 Nov; 10(5):950-7. PubMed ID: 15509512
[TBL] [Abstract][Full Text] [Related]
17. microRNA122-regulated transgene expression increases specificity of cardiac gene transfer upon intravenous delivery of AAV9 vectors.
Geisler A; Jungmann A; Kurreck J; Poller W; Katus HA; Vetter R; Fechner H; Müller OJ
Gene Ther; 2011 Feb; 18(2):199-209. PubMed ID: 21048795
[TBL] [Abstract][Full Text] [Related]
18. Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands.
Aldrich WA; Ren C; White AF; Zhou SZ; Kumar S; Jenkins CB; Shaw DR; Strong TV; Triozzi PL; Ponnazhagan S
Gene Ther; 2006 Jan; 13(1):29-39. PubMed ID: 16136165
[TBL] [Abstract][Full Text] [Related]
19. Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors.
Recchia A; Perani L; Sartori D; Olgiati C; Mavilio F
Mol Ther; 2004 Oct; 10(4):660-70. PubMed ID: 15451450
[TBL] [Abstract][Full Text] [Related]
20. Long-term in vivo cochlear transgene expression mediated by recombinant adeno-associated virus.
Lalwani A; Walsh B; Reilly P; Carvalho G; Zolotukhin S; Muzyczka N; Mhatre A
Gene Ther; 1998 Feb; 5(2):277-81. PubMed ID: 9578849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
